TENECTEPLASE vs TENOFOVIR DISOPROXIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TENECTEPLASE vs TENOFOVIR DISOPROXIL: Safety Overview
| Metric | TENECTEPLASE | TENOFOVIR DISOPROXIL |
|---|---|---|
| Total FAERS Reports | 1,319 | 26,978 |
| Deaths Reported | 310 | 1,235 |
| Death Rate | 23.5% | 4.6% |
| Hospitalizations | 314 | 3,617 |
| Average Patient Age | 66.2 yrs | 48.2 yrs |
| % Female Patients | 43.7% | 31.8% |
| FDA Approval Date | N/A | Dec 18, 2025 |
| Manufacturer | Genentech, Inc. | A-S Medication Solutions |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |